A Novel Function of MicroRNA 130A-3P in Hepatic Insulin Sensitivity and Liver Steatosis

Fei Xiao,Junjie Yu,Bin Liu,Yajie Guo,Kai Li,Jiali Deng,Jin Zhang,Chunxia Wang,Shanghai Chen,Ying Du,Yingli Lu,Yuzhong Xiao,Zhou Zhang,Feifan Guo
DOI: https://doi.org/10.2337/db13-1689
IF: 7.7
2014-01-01
Diabetes
Abstract:MicroRNAs (miRNAs) are endogenous, noncoding, short, single-stranded RNAs that are evolutionarily conserved and believed to play a role in controlling a variety of biological processes. The roles of miRNAs in insulin resistance and liver steatosis, however, are largely unknown. The objective of this study was to evaluate the roles of miR-130a in the regulation of insulin sensitivity and liver steatosis. In our current study, we observed that overexpression of miR-130a-3p increases insulin signaling in both HepG2 cells and primary mouse hepatocytes, and silencing of miR-130a-3p has the opposite effects. However, miR-130a-5p has no effect in the regulation of insulin signaling. Consistently, whole-body and hepatic insulin sensitivity are improved in mice injected with adenoviruses that overexpress miR-130a-3p. Furthermore, we provided evidence showing that growth factor receptor-bound protein 10 is required for miR-130a-3p-regulated insulin sensitivity. On the other hand, we observed that expression of miR-130a-3p is decreased in the livers of db/db mice and that adenovirus-mediated overexpression of miR-130a-3p reverses insulin resistance and liver steatosis, the latter of which is achieved via suppressing fatty acid synthase expression in these mice. This study identifies a novel function for hepatic miR-130a-3p in the regulation of insulin sensitivity and liver steatosis.
What problem does this paper attempt to address?